Innoviva, Inc. Contracts & Agreements

Offer Letter between Innoviva, Inc. and Stephen Basso, dated July 28, 2023 (Filed With SEC on August 25, 2023)

Equity Purchase Agreement, dated July 13, 2022, by and among Innoviva, Inc., Innoviva TRC Holdings LLC and Royalty Pharma Investments 2019 ICAV (Filed With SEC on July 13, 2022)

Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC (Filed With SEC on July 13, 2022)

Agreement and Plan of Merger, dated as of July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., and La Jolla Pharmaceutical Company (Filed With SEC on July 11, 2022)

Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and the Kevin C. Tang Foundation (Filed With SEC on July 11, 2022)

Agreement and Plan of Merger, dated as of May 23, 2022, by and among Innoviva, Inc., Innoviva Merger Sub, Inc., and Entasis Therapeutics Holdings Inc (Filed With SEC on May 24, 2022)

Amendment No. 1 to the Investor Rights Agreement, dated May 23, 2022, by and among Innoviva, Inc. and Entasis Therapeutics Holdings Inc (Filed With SEC on May 24, 2022)

Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated April 29, 2022 (Filed With SEC on May 2, 2022)

Indenture (including form of Note) with respect to Innovivas 2.125% Convertible Senior Notes due 2028, dated as of March 7, 2022, between Innoviva and The Bank of New York Mellon... (Filed With SEC on March 8, 2022)

Form of Capped Call Confirmation (Filed With SEC on March 8, 2022)

SHARE REPURCHASE AGREEMENT (Filed With SEC on May 20, 2021)

ISP FUND LP c/o Sarissa Capital Fund GP LP 660 Steamboat Road, 3rd Floor Greenwich, Connecticut 06830 (Filed With SEC on May 20, 2021)

Indemnification Agreement, dated as of March 9, 2021, by and between Innoviva, Inc. and Deborah L. Birx, M.D (Filed With SEC on April 28, 2021)

Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc (Filed With SEC on December 14, 2020)

Amended and Restated Limited Partnership Agreement of ISP Fund LP, dated as of December 11, 2020, by and among ISP Fund LP, Sarissa Capital Fund GP LP, Innoviva Strategic Partners... (Filed With SEC on December 14, 2020)

Transition Agreement between Innoviva, Inc. and Geoffrey L. Hulme, dated June 11, 2020 (Filed With SEC on June 12, 2020)

Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated May 20, 2020 (Filed With SEC on May 26, 2020)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2020)

Lease Termination Agreement between Innoviva, Inc. and HCP Life Science Reit, Inc (Filed With SEC on October 30, 2019)

Separation and Release Agreement between Innoviva, Inc. and George B. Abercrombie, dated October 1, 2018 (Filed With SEC on October 4, 2018)

Separation and Release Agreement between Innoviva, Inc. and Theodore J. Witek, Jr., dated October 1, 2018 (Filed With SEC on October 4, 2018)

Agreement between Innoviva, Inc. and Marianne Zhen dated as of September 7, 2018 (Filed With SEC on September 11, 2018)

Form of Indemnification Agreement between Innoviva, Inc. and its directors and executive officers (Filed With SEC on September 11, 2018)

Separation and Release Agreement between Innoviva, Inc. and Eric dEsparbes, dated August 8, 2018 (Filed With SEC on August 8, 2018)

Second Amendment to 2009 Severance Plan (Filed With SEC on July 26, 2018)

Offer Letter with Geoffrey Hulme dated as of May 18, 2018 (Filed With SEC on July 26, 2018)

Separation Letter between Innoviva, Inc. and Michael Faerm dated as of February 21, 2018 (Filed With SEC on May 4, 2018)

Form of Notice of Performance-Based Restricted Stock Award and Restricted Stock Award Agreement under 2012 Equity Incentive Plan (director form) (Filed With SEC on February 23, 2018)

Agreement, dated as of February 12, 2018, by and among Innoviva, Inc., Sarissa Capital Domestic Fund LP, and certain of its affiliates (Filed With SEC on February 13, 2018)

Agreement between Innoviva, Inc. and Eric dEsparbes dated as of February 7, 2018 (Filed With SEC on February 7, 2018)

Separation Letter between Innoviva, Inc. and Michael Aguiar dated as of February 6, 2018 (Filed With SEC on February 7, 2018)

INNOVIVA, INC. and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee INDENTURE Dated as of August 7, 2017 2.50% Convertible Senior Notes due 2025 (Filed With SEC on August 7, 2017)

[Signature Page to Termination Agreement] (Filed With SEC on February 28, 2017)

AMENDED AND RESTATED INDENTURE dated as of August 3, 2016 by and between LABA ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and... (Filed With SEC on November 3, 2016)

OFFICE LEASE by and between 2000 SIERRA POINT PARKWAY LLC, a Delaware limited liability company as Landlord and INNOVIVA, INC., a Delaware corporation, as Tenant 2000 Sierra Point... (Filed With SEC on August 4, 2016)

SUBLEASE TERMINATION AGREEMENT (Filed With SEC on August 4, 2016)

PARTIAL TERMINATION AGREEMENT dated as of May 16, 2016 Between INNOVIVA, INC. and BANK OF AMERICA, N.A. (Filed With SEC on August 4, 2016)

Relocation Assistance For Michael E. Faerm (Filed With SEC on February 24, 2016)

FIRST AMENDMENT TO 2009 CHANGE IN CONTROL SEVERANCE PLAN (RENAMED 2009 SEVERANCE PLAN) (Filed With SEC on July 29, 2015)

Relocation Assistance For Eric dEsparbes (Filed With SEC on February 27, 2015)

COLLABORATION AGREEMENT by and between THERAVANCE, INC. and GLAXO GROUP LIMITED Dated: November 14, 2002 (Filed With SEC on August 7, 2014)

EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on August 7, 2014)

THERAVANCE, INC. POLICY FOR NON-EMPLOYEE DIRECTOR STOCK OPTIONS EFFECTIVE JUNE 2, 2014 (Filed With SEC on August 7, 2014)

SEPARATION AND DISTRIBUTION AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014 (Filed With SEC on June 5, 2014)

TRANSITION SERVICES AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014 (Filed With SEC on June 5, 2014)

TAX MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014 (Filed With SEC on June 5, 2014)

EMPLOYEE MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014 (Filed With SEC on June 5, 2014)

THERAVANCE RESPIRATORY COMPANY, LLC LIMITED LIABILITY COMPANY AGREEMENT May 31, 2014 (Filed With SEC on June 5, 2014)

NOTE PURCHASE AGREEMENT dated April 17, 2014 among THERAVANCE, INC., LABA ROYALTY SUB LLC and THE PURCHASER NAMED HEREIN $450,000,000 LABA PHARMASM9.0% FIXED RATE TERM NOTES DUE... (Filed With SEC on April 21, 2014)

INDENTURE dated as of April 17, 2014 by and between LABA ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL... (Filed With SEC on April 21, 2014)

SALE AND CONTRIBUTION AGREEMENT dated as of April 17, 2014 between THERAVANCE, INC., as the Transferor and LABA ROYALTY SUB LLC, as the Transferee (Filed With SEC on April 21, 2014)

SERVICING AGREEMENT dated as of April 17, 2014 between LABA ROYALTY SUB LLC and THERAVANCE, INC. (Filed With SEC on April 21, 2014)

ACCOUNT CONTROL AGREEMENT (Filed With SEC on April 21, 2014)

LIMITED LIABILITY COMPANY AGREEMENT OF LABA ROYALTY SUB LLC (Filed With SEC on April 21, 2014)

ANNEX A RULES OF CONSTRUCTION AND DEFINED TERMS (Filed With SEC on April 21, 2014)

MASTER AGREEMENT (Filed With SEC on March 6, 2014)

THERAVANCE COLLABORATION AGREEMENT AMENDMENT (Filed With SEC on March 6, 2014)

THERAVANCE STRATEGIC ALLIANCE AGREEMENT AMENDMENT (Filed With SEC on March 6, 2014)

COLLABORATION AGREEMENT by and between THERAVANCE, INC. and GLAXO GROUP LIMITED Dated: November 14, 2002 (Filed With SEC on November 1, 2013)

THERAVANCE, INC. COMMON STOCK PURCHASE AGREEMENT July 30, 2013 (Filed With SEC on July 30, 2013)

COMMERCIALIZATION AGREEMENT by and between THERAVANCE, INC. and CLINIGEN GROUP PLC Dated: March 8, 2013 (Filed With SEC on May 1, 2013)

THERAVANCE, INC. 2.125% CONVERTIBLE SUBORDINATED NOTES DUE 2023 INDENTURE DATED AS OF JANUARY 24, 2013 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. AS TRUSTEE (Filed With SEC on January 25, 2013)

THERAVANCE, INC. (a Delaware corporation) 2.125% Convertible Subordinated Notes due 2023 UNDERWRITING AGREEMENT (Filed With SEC on January 23, 2013)

THERAVANCE, INC. 2012 EQUITY INCENTIVE PLAN (AS ADOPTED EFFECTIVE MAY 16, 2012) (Filed With SEC on August 1, 2012)

TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT (Filed With SEC on August 1, 2012)

[AMENDED AND RESTATED] INDEMNIFICATION AGREEMENT (Filed With SEC on May 2, 2012)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK AWARD (Filed With SEC on May 2, 2012)

THERAVANCE, INC. COMMON STOCK PURCHASE AGREEMENT April 2, 2012 (Filed With SEC on April 2, 2012)

AMENDMENT NO. 2 TO THE LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENT (Filed With SEC on January 6, 2012)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on November 2, 2011)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on November 2, 2011)

THERAVANCE, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED MAY 27, 2004 AND AMENDED ON APRIL 19, 2005, DECEMBER 11, 2007, DECEMBER 10, 2008, APRIL 27, 2010 AND FEBRUARY 11,... (Filed With SEC on May 4, 2011)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on May 4, 2011)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK AWARD (Filed With SEC on May 4, 2011)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN: PERFORMANCE CASH AWARD AGREEMENT (Filed With SEC on May 4, 2011)

THERAVANCE, INC. COMMON STOCK PURCHASE AGREEMENT [date] (Filed With SEC on May 4, 2011)

THERAVANCE, INC. December , 2010 (Filed With SEC on February 28, 2011)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on February 28, 2011)

THERAVANCE, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED MAY 27, 2004 ANDAMENDED ON APRIL 19, 2005, DECEMBER 11, 2007, DECEMBER 10, 2008 AND APRIL 27,2010) (Filed With SEC on August 4, 2010)

CONSULTING AGREEMENT (Filed With SEC on August 4, 2010)

FIRST AMENDMENT TO LEASE (Filed With SEC on August 4, 2010)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN (AS AMENDED AND RESTATED FEBRUARY 10, 2010) (Filed With SEC on May 5, 2010)

THERAVANCE, INC. 2008 NEW EMPLOYEE EQUITY INCENTIVE PLAN (AS ADOPTED EFFECTIVE JANUARY 29, 2008) (AS AMENDED JULY 21, 2009) (AS AMENDED DECEMBER 16, 2009) (Filed With SEC on May 5, 2010)

THERAVANCE, INC. (a Delawarecorporation) 7,500,000 Sharesof Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on March 24, 2010)

Theravance, Inc. CashBonus Program, amended effective as of February 10, 2010 (Filed With SEC on February 26, 2010)

FIRST AMENDMENT TO AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE PLAN (Filed With SEC on February 26, 2010)

THERAVANCE, INC. 2009 CHANGE IN CONTROL SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (As adopted by the Boardof Directors on December 16, 2009) (Filed With SEC on February 26, 2010)

THERAVANCE, INC. 2008 NEW EMPLOYEE EQUITYINCENTIVE PLAN (AS ADOPTED EFFECTIVEJANUARY 29, 2008) (AS AMENDED JULY 21, 2009) (Filed With SEC on August 5, 2009)

THERAVANCE, INC. 2004EMPLOYEE STOCK PURCHASE PLAN (ASADOPTED MAY 27, 2004 AND AMENDED ON APRIL 19, 2005, DECEMBER 11, 2007 ANDDECEMBER 10, 2008) (Filed With SEC on May 7, 2009)

THERAVANCE, INC. 2004EQUITY INCENTIVE PLAN NOTICE OF RESTRICTEDSTOCK UNIT AWARD (Filed With SEC on May 7, 2009)

THERAVANCE,INC. 2004 EQUITY INCENTIVE PLAN NOTICEOF RESTRICTED STOCK UNIT AWARD (Filed With SEC on February 27, 2009)

THERAVANCE, INC. 2004EQUITY INCENTIVE PLAN NOTICE OF RESTRICTEDSTOCK UNIT AWARD (Filed With SEC on February 27, 2009)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on December 11, 2008)

CONSULTINGAGREEMENT (Filed With SEC on December 11, 2008)

AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT (Filed With SEC on November 25, 2008)

THERAVANCE, INC. 2008NEW EMPLOYEE EQUITY INCENTIVE PLAN NOTICE OF RESTRICTEDSTOCK UNIT AWARD (Filed With SEC on November 6, 2008)

THERAVANCE,INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (As amended July 27, 2007) (Filed With SEC on August 7, 2008)

THERAVANCE, INC. 2004EQUITY INCENTIVE PLAN NOTICE OF RESTRICTEDSTOCK UNIT AWARD (Filed With SEC on August 7, 2008)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 7, 2008)

CONSULTINGAGREEMENT (Filed With SEC on June 19, 2008)

THERAVANCE, INC. 2004EMPLOYEE STOCK PURCHASE PLAN (ASADOPTED MAY 27, 2004 AND AMENDED ON APRIL 19, 2005 AND DECEMBER 11, 2007) (Filed With SEC on May 8, 2008)

THERAVANCE, INC. 2004EQUITY INCENTIVE PLAN NOTICE OF RESTRICTEDSTOCK UNIT AWARD (Filed With SEC on May 8, 2008)

THERAVANCE,INC. (aDelaware corporation) 3%Subordinated Convertible Notes due 2015 PURCHASE AGREEMENT (Filed With SEC on January 23, 2008)

THERAVANCE, INC. 3% CONVERTIBLE SUBORDINATED NOTES DUE 2015 INDENTURE DATED AS OF JANUARY 23, 2008 THE BANK OF NEW YORK TRUST COMPANY, N.A. AS TRUSTEE (Filed With SEC on January 23, 2008)

FIRSTADDENDUM TO THE TERMS & CONDITIONS DATED FEBRUARY 17, 2004 THERAVANCE, INC. AND BEN VENUELABORATORIES, INC. (Filed With SEC on November 7, 2007)

THERAVANCE, INC. and The Bank of NewYork, as Rights Agent AMENDED AND RESTATED RIGHTS AGREEMENT Dated as of June 22, 2007 (Filed With SEC on August 8, 2007)

Theravance, Inc. 2004Equity Incentive Plan Notice of Restricted Stock Award (Filed With SEC on August 8, 2007)

THERAVANCE, INC. 2004 EQUITYINCENTIVE PLAN NOTICE OFSTOCK OPTION GRANT (Filed With SEC on August 8, 2007)

Theravance,Inc. 2004 Equity Incentive Plan Noticeof Stock Option Grant (Filed With SEC on August 8, 2007)

THERAVANCE,INC. 2004 EQUITY INCENTIVE PLAN NOTICEOF RESTRICTED STOCK UNIT AWARD (Filed With SEC on August 8, 2007)

SHARES (Filed With SEC on March 1, 2007)

THERAVANCE, INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (Filed With SEC on March 1, 2007)

Theravance,Inc. CashBonus Program, amended effective as of February 28, 2007 (Filed With SEC on March 1, 2007)

THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN (AS ADOPTED MAY 27, 2004 AND AMENDED DECEMBER6, 2006) (Filed With SEC on March 1, 2007)

AMENDMENT TO LICENSE,DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT (Filed With SEC on November 6, 2006)

SUPPLY AGREEMENT TD-6424 ActivePharmaceutical Ingredient BY AND BETWEEN THERAVANCE, INC., SCINOPHARM TAIWAN,LTD. AND BIDDLE SAWYERPHARMA LLC (Filed With SEC on August 4, 2006)

Theravance, Inc. Cash Bonus Program (Filed With SEC on March 8, 2006)

THERAVANCE, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED MAY 27, 2004 AND AMENDED ON APRIL 19,2005) (Filed With SEC on August 12, 2005)

CONSULTINGAGREEMENT (Filed With SEC on August 12, 2005)

THERAVANCE,INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK AWARD (Filed With SEC on August 12, 2005)

THERAVANCE, INC. 2004 EMPLOYEESTOCK PURCHASE PLAN (ASADOPTED MAY 27, 2004 AND AMENDED ON APRIL 19, 2005) (Filed With SEC on May 13, 2005)

THERAVANCE, INC. 2004EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTIONGRANT (Filed With SEC on March 29, 2005)

THERAVANCE,INC. 2004 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK AWARD (Filed With SEC on March 29, 2005)

THERAVANCE, INC. and American Stock Transfer &Trust Company, as Rights Agent RIGHTS AGREEMENT Dated as of October 8,2004 (Filed With SEC on November 17, 2004)

Category

Industry

Companies

Contracts

Innoviva, Inc. Contracts & Agreements